Latest Share Chat

REMOVE ADS

SLN.L Regulatory News (SLN)

SLN.L Information

There is currently no data for SLN

REMOVE ADS

Proposed Placing

21 Nov 2012 07:00

RNS Number : 6362R

Silence Therapeutics PLC

21 November 2012

Proposed Placing

London, 21 November, 2012 - Silence Therapeutics plc (AIM: SLN) ("Silence" or the "Company"), announces that the Company is in advanced discussions to raise additional funds from a strategic partner and existing shareholders through the issue of new ordinary shares.

The proposed issue of new ordinary shares is not expected to require shareholder approval.

Further details will be announced in due course.

-Ends-

Silence Therapeutics

Ali Mortazavi (+44 7768 694739 /Tim Freeborn (+44 20 7491 6520)

Email: a.mortazavi@silence-therapeutics.com

t.freeborn@silence-therapeutics.com

N+1 Singer

Shaun Dobson/Jennifer Wyllie

+44 20 7496 3000

shaun.dobson@n1singer.com

jenny.wyllie@n1singer.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCDBBDBDDDBGDG

Date		Source	Headline
26th May 2005	3:40 pm	PRN	Final Results
3rd May 2005	2:13 pm	PRN	Merger Update
24th Feb 2005	11:03 am	PRN	Holding(s) in Company
9th Feb 2005	1:48 pm	PRN	Holding(s) in Company
9th Feb 2005	1:45 pm	PRN	Holding(s) in Company
7th Feb 2005	2:43 pm	PRN	EGM Statement
21st Jan 2005	10:06 am	PRN	Notice of EGM
12th Jan 2005	2:25 pm	PRN	Holding(s) in Company
6th Jan 2005	10:13 am	PRN	Holding(s) in Company

Latest Share Chat

SLN.L Regulatory News (SLN)

Proposed Placing

Please enter at least 2 characters

No results found

Search results

Recently viewed

Trending